×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: covid | pfizer | biontech se | vaccine | omicron | bq.1.1 | variant

Pfizer Omicron Shot Produces Antibodies Against Emerging BQ.1.1 Subvariant

BQ.1.1 green COVID virus particle
(Dreamstime)

Friday, 18 November 2022 07:01 AM EST

Pfizer Inc and its German partner BioNTech SE said on Friday their omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.

Antibody levels against the variant rose nearly 9 times in older adults, aged 55 and above, who received the omicron shot compared to a 2-fold increase in participants with the original shot, according to data posted on the online archive bioRxiv.

BQ.1.1 variant, which is closely related to the BA.5 omicron subvariant, was estimated to account for about 24.1% of the COVID-19 cases in United States, as of Nov. 12.

Pfizer and BioNtech said the bivalent shot also produced an immune response against newer omicron subvariants including BA.4.6, BA.2.75.2 and XBB.1.

The companies had recently released data that showed their omicron-tailored shot produced a strong antibody response in older adults than the original shot after one month against BA.4/5 subvariants.

Based on data from preclinical studies, omicron-tailored shots made by Pfizer and rival Moderna Inc have already been approved in the United States for adults and for children as young as five years. 

© 2023 Thomson/Reuters. All rights reserved.


Health-News
Pfizer Inc and its German partner BioNTech SE said on Friday their omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine. Antibody levels against the variant rose nearly 9 times in...
covid, pfizer, biontech se, vaccine, omicron, bq.1.1, variant, antibodies
183
2022-01-18
Friday, 18 November 2022 07:01 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved